CANTON, Conn., May 14, 2012 /PRNewswire/ -- Kelyniam
(Pinksheets: KLYG.PK) On May
11th at 2pm, local time, the
2012 Annual Meeting of Stockholders of Kelyniam Global Inc. was
held at the company's headquarters located at 97 River Road,
Canton, CT 06019. The
matters listed below were submitted to a vote of the shareholders
through solicitation of proxies. The final results of the
shareholder votes are as follows:
Proposal 1 – Amendment to Articles of Incorporation – Increase
of Authorized Shares
The shareholders approved the proposal to increase the
authorized shares of common stock from 20,000,000 to 60,000,000
shares.
|
For
|
9,086,522
|
|
Against
|
1,435,015
|
Proposal 2 – Amendment to Articles of Incorporation –
Authorization of Creation of a Preferred Class
The shareholders approved the proposal to authorize a creation
of a preferred class of shares.
|
For
|
7,654,377
|
|
Against
|
2,867,160
|
Proposal 3 – Election of Directors
The shareholders elected each director nominated to serve for a
term of one year.
|
a.)
Tennyson S. Anthony Esq.
|
|
For
|
9,232,528
|
|
Against
|
1,275,509
|
|
b.)
Nicholas Breault
|
|
For
|
10,475,037
|
|
Against
|
33,000
|
|
c.)
Dr. Christopher Mirucki
|
|
For
|
10,062,228
|
|
Against
|
445,809
|
|
d.)
Christopher Breault
|
|
For
|
9,138,089
|
|
Against
|
1,369,948
|
About Kelyniam Global, Incorporated
Kelyniam Global (Pinksheets: KLYG), Inc. specializes in the use
of CAD/CAM technology to provide patient specific custom implants
to assist medical professionals by allowing them to operate more
effectively, improve patient care, and reduce health care costs by
providing the highest quality products available with today's
technology. The company is continually researching and developing
new products and processes to help patients live more active and
productive lives.
Please visit our website at www.kelyniam.com for more
information.
Forward-Looking Statements
Except for historical information contained in this release, the
matters discussed are forward-looking statements that involve risks
and uncertainties. When used in this release, words such as
"anticipate," "believes," "estimate," "expect," "should," "intend,"
"projects," "objective" and "appears" and similar expressions, as
they relate to the Company or its management, identify
forward-looking statements. Such forward-looking statements are
based on the beliefs of the Company's management, as well as
assumptions made by and information currently available to the
Company's management. Among the factors that could cause actual
results to differ materially are the following: the effect of
business and economic conditions; the impact of competitive
products and pricing; capacity and supply constraints or
difficulties; product development, commercialization or
technological difficulties; the regulatory and trade environment;
the impact of reimbursement rates and coverage; and the risk
factors reported from time to time in the Company's SEC reports.
The Company undertakes no obligation to revise any forward-looking
statements as a result of future events or developments.
For Question regarding this Press Release, please contact:
Kelyniam Global Inc.
Michael Hamblett,
800-280-8192 x3
Director of Investor Relations
SOURCE Kelyniam